![[C3MPr]NTf2](/upload/1124/V66434.png)
| Size | Price | |
|---|---|---|
| Other Sizes |
| Targets |
There is no biological target for this compound. It is an ionic liquid that may interact with cell membranes if accidentally released, but it has no specific molecular target. Its primary function is as a solvent or electrolyte in materials science.
|
|---|---|
| ln Vitro |
No in vitro biological activity is reported. In electrochemical assays, [C3MPr]NTf2 exhibits high ionic conductivity (2-10 mS/cm at 25degC), wide electrochemical window (up to 5.5 V vs. Li+/Li), and high thermal stability (decomposition >300degC). It is used as a non-aqueous electrolyte.
|
| ln Vivo |
No in vivo activity is reported. This compound is not used in animals. It is a chemical reagent for non-biological applications.
|
| Enzyme Assay |
Not applicable. A standard electrochemical protocol: [C3MPr]NTf2 is mixed with a lithium salt (e.g., LiTFSI) to 1 M concentration. The solution is degassed and used as an electrolyte in a two-electrode or three-electrode cell with metallic lithium or graphite electrodes. Cyclic voltammetry is performed at scan rates of 0.1-10 mV/s.
|
| Cell Assay |
No cell-based protocol exists. Ionic liquids can be cytotoxic due to membrane disruption. For cytotoxicity testing, cells (e.g., HeLa or PC12) are exposed to [C3MPr]NTf2 at concentrations of 0.1-10 mM for 24-72 hours, and viability is measured by MTT. However, this is not standard use.
|
| Animal Protocol |
No standard in vivo protocol. If accidental exposure occurs in animals, toxicity studies would be performed, but it is not intentionally administered.
|
| ADME/Pharmacokinetics |
PK properties are not applicable. The ionic liquid has negligible volatility and is not absorbed systemically under normal handling. It is miscible with some organic solvents but immiscible with water. Formulation is as neat liquid or in organic solvents.
|
| Toxicity/Toxicokinetics |
Toxicity: Ionic liquids can be toxic to aquatic organisms. [C3MPr]NTf2 may be irritating to skin and eyes, and aspiration into lungs is harmful. It is not considered highly toxic orally (LD50 >2000 mg/kg in rats for similar ionic liquids). Handle with PPE (gloves, goggles) in a well-ventilated area.
|
| Additional Infomation |
[C3MPr]NTf2 is a room-temperature ionic liquid used in energy storage devices (supercapacitors, lithium-ion batteries), electrodeposition, and as a green solvent for organic synthesis. Its high electrochemical stability makes it suitable for high-voltage applications. This product is for research use only.
|
| Molecular Formula |
C10H18F6N2O4S2
|
|---|---|
| Molecular Weight |
408.38
|
| Exact Mass |
408.061
|
| CAS # |
223437-05-6
|
| PubChem CID |
25171607
|
| Appearance |
Colorless to light yellow liquid（Density：1.44 g/cm3）
|
| Melting Point |
12 °C
|
| Index of Refraction |
1.42
|
| LogP |
4.816
|
| Hydrogen Bond Donor Count |
0
|
| Hydrogen Bond Acceptor Count |
11
|
| Rotatable Bond Count |
4
|
| Heavy Atom Count |
24
|
| Complexity |
456
|
| Defined Atom Stereocenter Count |
0
|
| SMILES |
CCC[N+]1(C)CCCC1.C(F)(F)(F)S(=O)(=O)[N-]S(=O)(=O)C(F)(F)F
|
| InChi Key |
DKNRELLLVOYIIB-UHFFFAOYSA-N
|
| InChi Code |
InChI=1S/C8H18N.C2F6NO4S2/c1-3-6-9(2)7-4-5-8-9;3-1(4,5)14(10,11)9-15(12,13)2(6,7)8/h3-8H2,1-2H3;/q+1;-1
|
| Chemical Name |
bis(trifluoromethylsulfonyl)azanide;1-methyl-1-propylpyrrolidin-1-ium
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: Please store this product in a sealed and protected environment, avoid exposure to moisture. |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
May dissolve in DMSO (in most cases), if not, try other solvents such as H2O, Ethanol, or DMF with a minute amount of products to avoid loss of samples
|
|---|---|
| Solubility (In Vivo) |
Note: Listed below are some common formulations that may be used to formulate products with low water solubility (e.g. < 1 mg/mL), you may test these formulations using a minute amount of products to avoid loss of samples.
Injection Formulations
Injection Formulation 1: DMSO : Tween 80： Saline = 10 : 5 : 85 (i.e. 100 μL DMSO stock solution → 50 μL Tween 80 → 850 μL Saline)(e.g. IP/IV/IM/SC) *Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH ₂ O to obtain a clear solution. Injection Formulation 2: DMSO : PEG300 ：Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL DMSO → 400 μLPEG300 → 50 μL Tween 80 → 450 μL Saline) Injection Formulation 3: DMSO : Corn oil = 10 : 90 (i.e. 100 μL DMSO → 900 μL Corn oil) Example: Take the Injection Formulation 3 (DMSO : Corn oil = 10 : 90) as an example, if 1 mL of 2.5 mg/mL working solution is to be prepared, you can take 100 μL 25 mg/mL DMSO stock solution and add to 900 μL corn oil, mix well to obtain a clear or suspension solution (2.5 mg/mL, ready for use in animals). View More
Injection Formulation 4: DMSO : 20% SBE-β-CD in saline = 10 : 90 [i.e. 100 μL DMSO → 900 μL (20% SBE-β-CD in saline)] Oral Formulations
Oral Formulation 1: Suspend in 0.5% CMC Na (carboxymethylcellulose sodium) Oral Formulation 2: Suspend in 0.5% Carboxymethyl cellulose Example: Take the Oral Formulation 1 (Suspend in 0.5% CMC Na) as an example, if 100 mL of 2.5 mg/mL working solution is to be prepared, you can first prepare 0.5% CMC Na solution by measuring 0.5 g CMC Na and dissolve it in 100 mL ddH2O to obtain a clear solution; then add 250 mg of the product to 100 mL 0.5% CMC Na solution, to make the suspension solution (2.5 mg/mL, ready for use in animals). View More
Oral Formulation 3: Dissolved in PEG400 (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.4487 mL | 12.2435 mL | 24.4870 mL | |
| 5 mM | 0.4897 mL | 2.4487 mL | 4.8974 mL | |
| 10 mM | 0.2449 mL | 1.2243 mL | 2.4487 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration： mg/mL；
Method for preparing DMSO stock solution： mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation:：Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O，mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
